Brainstorm?s
cell therapy succeeds in ALS
mid-stage study
(Reuters) - Brainstorm
cell Therapeutics Inc said its experimental
cell therapy was safe and well tolerated in patients with amyotrophic lateral sclerosis (ALS), a progressive neurological disorder, in a
mid-stage study.
